Earnings call transcript: PACS Group Q3 2026 earnings beat growth, stock jumps

PACS Group’s Q3 2026 revenue rose 11.5% to about $1.5 billion and adjusted EBITDA increased 33.6% to $175.7 million, with adjusted EBITDA margin expanding 190 basis points to 11.7%; same-store occupancy improved 200 basis points to 91.3%. Adjusted EPS was reported at $0.27 versus a $0.55 forecast, a 50.9% miss, while management raised full-year 2026 revenue guidance to $5.95 billion–$6.05 billion and adjusted EBITDA guidance to $685 million–$695 million. Shares gained 10.63% to $51.64 in after-hours trading, near their 52-week high, as investors appeared to favor stronger operations and guidance over the EPS shortfall.

Analysis

The positive reaction looks like a rerating of operating execution, but the near-term setup is less clean than the guidance headline suggests. Same-store occupancy and skilled mix support revenue quality; the larger upside case depends on converting recently acquired, lower-performing facilities toward mature-cohort levels. That is an execution option, not yet proven earnings power: integration costs arrive first, while occupancy, referral relationships, and quality-linked reimbursement may take quarters to improve. Expansion into Florida also increases exposure to a new regulatory, labor, and reimbursement environment.

There is a material source-data issue to resolve before underwriting the EPS response. The article gives adjusted EPS of $0.63, consistent with the call, but separately claims adjusted EPS was $0.27 versus $0.55 expected. Those figures conflict; do not treat the stated 50.9% miss as verified. Obtain the earnings release and reconciliation. Also separate recurring operations from the Ohio retroactive payment and other state incentive receipts; these should not be annualized mechanically. Improved collections supported reported cash conversion, so test whether that persists.

At the reported after-hours level, the shares are near their recent high after a sharp gap, while the operating thesis still hinges on acquisition execution and unresolved investigations. A pullback may offer a better entry than chasing; near term, price discovery and validation of the EPS data are the catalysts. Over 1–3 months, watch facility-level occupancy/skilled-mix progression, integration spending, and control-remediation testing. Over 6–18 months, successful ramping could support earnings growth; regulatory outcomes, labor costs, reimbursement changes, or stalled acquisition performance could reverse the thesis.

Key Decisions for Investors

• Do not chase the after-hours gap. Keep PACS on a pullback watchlist and size any eventual long only after reconciling adjusted EPS against the official release and confirming the guidance bridge.
• Track acquired-facility cohorts against the reported starting baselines: occupancy of 76.2% for new facilities versus 93.1% for mature facilities, and skilled mix of 21.1% versus 31.3%. Failure to show sequential improvement over coming quarters would weaken the acquisition-led growth case.
• Treat the Ohio retroactive incentive and state supplemental payments as nonrecurring unless management establishes a durable rate contribution. Monitor same-store growth, cash collections/DSO, and integration costs separately from acquisition-driven revenue.
• Reassess on formal completion of internal-control effectiveness testing and any development in the ongoing government investigations. These are company-specific downside catalysts that strong operating trends do not eliminate.